For liver transplant recipients without alcohol use disorder who report low-level alcohol use post-transplant, what objective monitoring strategy (e.g., phosphatidylethanol trends and liver injury/fibrosis assessments) and escalation triggers do you use to decide when to intensify follow- up or involve addiction medicine?